Through PK-PD Modeling & Simulation, predict PK-PD in humans based on preclinical test data and predict optimal dosage and usage in early clinical trials, thereby increasing the value of new drugs under development and shortening the clinical entry time as much as possible.
Provides effective and efficient development strategies
Identification of drug characteristics and future prediction through PK-PD modeling
- Prediction of PK-PD in humans through modeling & simulation based on cell and animal experiment results
- Establish future development strategies by identifying drug characteristics through PK-PD Modeling from the discovery or preclinical stage
- Initial clinical trial design such as first in human study
Service
- PK-PD analysis
- Group PK-PD modeling analysis using NONMEM.
- System Pharmacology, Physiology-Based PK (PBPK) modeling
- Clinical trial simulation
- IVIVC(In vitro, in vivo Correlation)
- First in human clinical trial design
- User-friendly tool for field application of modeling results
- Create results reports based on reproducible research
PK-PD Simulation